Responding to the latest Global Commission on Drug Policy report
Our Medical Director, Dr Prun Bijral, responds to the Global Commission on Drug Policy's report: Regulation - The Responsible Control of Drugs.
On the 24 September 2018 The Global Commission on Drug Policy published a report that calls for governments worldwide to investigate regulated drug markets to reduce harm and violence. They assert that regulation and management of risky products and behaviours is a universally accepted evidence-based approach, and is a key function of government authorities across the world. They go on to argue that taking this approach, in the context of drugs, would address the reality for the estimated 250m people worldwide who are consuming currently prohibited drugs, and reduce the impact from the numerous associated risks.
The report identifies a number of key questions to be engaged with directly to progress the dialogue on the responsible control of drugs, and goes on make seven associated recommendations underpinned by a set of governance principles.
Change Grow Live has considered this report in the context of our mission and values; to help people change the direction of their lives, grow as a person and live life to its full potential. We believe in empowering people to make informed and positive choices about their lives, respecting their individuality and uniqueness, and championing those who are unfairly challenged by health and social inequality.
We recognise that the Commission has promoted taking an evidence-based approach, kept at heart the wellbeing and human rights of some of the most marginalised members of our global community, while comprehensively acknowledging the very real challenges of changing the current approaches to drug control.
We believe that Change Grow Live service users and colleagues would broadly support the report’s findings, and that the recommendations made are in line with our own stated mission and values, while acknowledging the significant number of caveats and cautions that must be considered in conjunction with the key recommendations. We agree that the recommendations could support the stated aims to get greater control of the current drug problem, address the challenges of implementing regulation, positively impact on addressing organised crime, and deliver much-needed modernisation of the current international drug control system.